8-K
Current Report
Larimar Therapeutics, Inc. Filed Acc 0001193125-26-407331
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading lrmr-20260929.htm…